KaydedilenlerDerginizi ekleyin

Dergiler / Journal of Surgery and Medicine / 2021 / Cilt: 5 - Sayı: 6

Association of circulating preptin with non-alcoholic fatty liver disease: A case-control study

Derya ARĞUN
Pelin BASİM
Betül BÖRKÜ UYSAL
Ferit ARGUN
Sayfa
628–632
Yayın Tarihi
2021-06-01
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Results: The serum preptin levels were higher in the NAFLD group than in the control cases (P

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/Aim: Non-alcoholic fatty liver disease (NAFLD) is the hepatic component of metabolic disorders and identifying patients with a high risk of fibrosis is crucial.
📊
Temel Bulgular & Veri:A scoring system, the FIB-4 score, based on clinical and biochemical parameters was developed to predict fibrosis.
💡
Sonuç & Katkı:Results: The serum preptin levels were higher in the NAFLD group than in the control cases (P
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Preptin · Hepatosteatosis · Non-alcoholic fatty liver disease

Abstract

Background/Aim: Non-alcoholic fatty liver disease (NAFLD) is the hepatic component of metabolic disorders and identifying patients with a high risk of fibrosis is crucial. A scoring system, the FIB-4 score, based on clinical and biochemical parameters was developed to predict fibrosis. NAFLD is associated with various peptide hormones. However, the relationship of preptin, a newly discovered peptide critical for regulating energy metabolism, with NAFLD remains unclear. Therefore, we aimed to determine the relationship of preptin with NAFLD and evaluate whether there was an association between serum preptin levels and FIB-4 score. Methods: In this prospective study, serum biochemical parameters and serum preptin levels of 51 patients with grade 2-3 hepatosteatosis proven by ultrasonography and 35 healthy controls with similar demographic characteristics were compared. Serum preptin levels were measured using ELISA. The FIB-4 scores were calculated and recorded. Results: The serum preptin levels were higher in the NAFLD group than in the control cases (P

🔖

Bu Makaleye Atıf Yap

ARĞUN, D., BASİM, P., UYSAL, B. B., ARGUN, F. (2021). Association of circulating preptin with non-alcoholic fatty liver disease: A case-control study. Journal of Surgery and Medicine, Cilt: 5 - Sayı: 6, 628–632. https://ajindex.com/articles/779917

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Milić S, Lulić D, Štimac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol. 2014;20:9330-7
  2. Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018;67:328-57
  3. Fazel Y, Koenig AB, Sayiner M, Goodman ZD, Younossi ZM. Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism 2016;65:1017-25
  4. Mishra A, Younossi ZM. Epidemiology and natural history of non-alcoholic fatty liver disease. J Clin Exp Hepatol. 2012;2:135-44
  5. Mallet V, Parlati L, Vallet-Pichard A, Terris B, Tsochatzis E, Sogni P, et al. FIB-4 index to rule-out advanced liver fibrosis in NAFLD patients. Presse Med. 2019;48:1484-88
  6. Adolph TE, Grander C, Grabherr F, Tilg H. Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions. Int J Mol Sci. 2017;29:1649
  7. Kutlu O, Altun Ö, Dikker O, Aktaş Ş, Özsoy N, Arman Y, et al. Serum Adropin Levels Are Reduced in Adult Patients with Nonalcoholic Fatty Liver Disease. Med Princ Pract. 2019;28:463-9
  8. Dallio M, Masarone M, Caprio GG, Sarno RD, Tuccillo C, Sasso FC, et al. Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study. J Gastrointestin Liver Dis. 2017;26:261-268
  9. Cornish J, Callon KE, Bava U, Watson M, Xu X, Lin JM, et al. Preptin, another peptide product of the pancreatic β-cell, is osteogenic in vitro and in vivo. Am J Physiol Endocrinol Metab. 2007;292:117-22
  10. Buchanan CM, Philips AR, Cooper GJ. Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet beta-cells and enhances insulin secretion. Biochem J. 2001;360:431-9
  11. Aydın S, Celik O, Gurates B, Sahin I, Ulas M, Yilmaz M, et al. Concentrations of preptin, salusins and hepcidins in plasma milk of lactating women with or without gestational diabetes mellitus. Peptides 2013;49:123-30
  12. Aydin S. Three new players in energy regulation: preptin, adropin and irisin. Peptides. 2014;56:94-110
  13. Aslan M, Celik O, Karsavuran N, Celik N, Dogan DG, Botan E, et al. Maternal serum and cord blood preptin levels in gestational diabetes mellitus. J Perinatol. 2011;31:350–5
  14. Celik O, Celik N, Hascalik S, Sahin I, Aydin S, Ozerol E. An appraisal of serum preptin levels in PC